nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—blood vessel—stomach cancer	0.0245	0.122	CbGeAlD
Ingenol Mebutate—PRKCD—hematopoietic system—stomach cancer	0.0237	0.118	CbGeAlD
Ingenol Mebutate—PRKCD—lymphoid tissue—stomach cancer	0.0167	0.0833	CbGeAlD
Ingenol Mebutate—PRKCD—bone marrow—stomach cancer	0.0152	0.0758	CbGeAlD
Ingenol Mebutate—PRKCD—endocrine gland—stomach cancer	0.0136	0.068	CbGeAlD
Ingenol Mebutate—PRKCA—hematopoietic system—stomach cancer	0.013	0.0652	CbGeAlD
Ingenol Mebutate—PRKCD—liver—stomach cancer	0.0123	0.0613	CbGeAlD
Ingenol Mebutate—PRKCA—epithelium—stomach cancer	0.0119	0.0596	CbGeAlD
Ingenol Mebutate—PRKCA—smooth muscle tissue—stomach cancer	0.0115	0.0574	CbGeAlD
Ingenol Mebutate—PRKCA—pancreas—stomach cancer	0.0106	0.0531	CbGeAlD
Ingenol Mebutate—Application site burn—Fluorouracil—stomach cancer	0.00975	0.107	CcSEcCtD
Ingenol Mebutate—PRKCD—lymph node—stomach cancer	0.0094	0.047	CbGeAlD
Ingenol Mebutate—PRKCA—lymphoid tissue—stomach cancer	0.00918	0.0459	CbGeAlD
Ingenol Mebutate—PRKCA—digestive system—stomach cancer	0.00907	0.0454	CbGeAlD
Ingenol Mebutate—PRKCA—endocrine gland—stomach cancer	0.00749	0.0375	CbGeAlD
Ingenol Mebutate—PRKCA—liver—stomach cancer	0.00676	0.0338	CbGeAlD
Ingenol Mebutate—Scab—Fluorouracil—stomach cancer	0.00643	0.0704	CcSEcCtD
Ingenol Mebutate—Ulcer—Mitomycin—stomach cancer	0.00519	0.0569	CcSEcCtD
Ingenol Mebutate—PRKCA—lymph node—stomach cancer	0.00518	0.0259	CbGeAlD
Ingenol Mebutate—Application site pain—Fluorouracil—stomach cancer	0.00465	0.0509	CcSEcCtD
Ingenol Mebutate—Scab—Capecitabine—stomach cancer	0.00449	0.0492	CcSEcCtD
Ingenol Mebutate—Erythema—Floxuridine—stomach cancer	0.00274	0.03	CcSEcCtD
Ingenol Mebutate—Ulcer—Irinotecan—stomach cancer	0.00226	0.0247	CcSEcCtD
Ingenol Mebutate—Infection—Floxuridine—stomach cancer	0.00222	0.0243	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Floxuridine—stomach cancer	0.00219	0.024	CcSEcCtD
Ingenol Mebutate—Ulcer—Fluorouracil—stomach cancer	0.00216	0.0237	CcSEcCtD
Ingenol Mebutate—Erythema—Mitomycin—stomach cancer	0.00215	0.0235	CcSEcCtD
Ingenol Mebutate—Swelling—Fluorouracil—stomach cancer	0.00168	0.0184	CcSEcCtD
Ingenol Mebutate—Ulcer—Capecitabine—stomach cancer	0.00151	0.0165	CcSEcCtD
Ingenol Mebutate—Headache—Floxuridine—stomach cancer	0.0014	0.0153	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Fluorouracil—stomach cancer	0.00133	0.0145	CcSEcCtD
Ingenol Mebutate—Swelling—Docetaxel—stomach cancer	0.00121	0.0133	CcSEcCtD
Ingenol Mebutate—Swelling—Capecitabine—stomach cancer	0.00118	0.0129	CcSEcCtD
Ingenol Mebutate—Eye pain—Capecitabine—stomach cancer	0.00115	0.0126	CcSEcCtD
Ingenol Mebutate—Infestation—Fluorouracil—stomach cancer	0.00114	0.0125	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Fluorouracil—stomach cancer	0.00114	0.0125	CcSEcCtD
Ingenol Mebutate—Ulcer—Methotrexate—stomach cancer	0.00112	0.0123	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Fluorouracil—stomach cancer	0.00111	0.0122	CcSEcCtD
Ingenol Mebutate—Headache—Mitomycin—stomach cancer	0.0011	0.012	CcSEcCtD
Ingenol Mebutate—Ulcer—Epirubicin—stomach cancer	0.00105	0.0115	CcSEcCtD
Ingenol Mebutate—Ulcer—Doxorubicin—stomach cancer	0.000973	0.0107	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Docetaxel—stomach cancer	0.000957	0.0105	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Capecitabine—stomach cancer	0.000927	0.0102	CcSEcCtD
Ingenol Mebutate—Erythema—Fluorouracil—stomach cancer	0.000893	0.00978	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Docetaxel—stomach cancer	0.000825	0.00904	CcSEcCtD
Ingenol Mebutate—Infestation—Docetaxel—stomach cancer	0.000825	0.00904	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Docetaxel—stomach cancer	0.000802	0.00878	CcSEcCtD
Ingenol Mebutate—Eye pain—Epirubicin—stomach cancer	0.0008	0.00876	CcSEcCtD
Ingenol Mebutate—Infestation—Capecitabine—stomach cancer	0.000799	0.00875	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Capecitabine—stomach cancer	0.000799	0.00875	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Capecitabine—stomach cancer	0.000777	0.0085	CcSEcCtD
Ingenol Mebutate—Infection—Irinotecan—stomach cancer	0.000756	0.00828	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Irinotecan—stomach cancer	0.000747	0.00818	CcSEcCtD
Ingenol Mebutate—Eye pain—Doxorubicin—stomach cancer	0.00074	0.00811	CcSEcCtD
Ingenol Mebutate—Infection—Fluorouracil—stomach cancer	0.000724	0.00793	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Fluorouracil—stomach cancer	0.000715	0.00783	CcSEcCtD
Ingenol Mebutate—Eye disorder—Docetaxel—stomach cancer	0.000692	0.00758	CcSEcCtD
Ingenol Mebutate—Eye disorder—Capecitabine—stomach cancer	0.00067	0.00734	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Epirubicin—stomach cancer	0.000646	0.00707	CcSEcCtD
Ingenol Mebutate—Erythema—Docetaxel—stomach cancer	0.000645	0.00706	CcSEcCtD
Ingenol Mebutate—Erythema—Capecitabine—stomach cancer	0.000624	0.00684	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Doxorubicin—stomach cancer	0.000598	0.00654	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Methotrexate—stomach cancer	0.000595	0.00651	CcSEcCtD
Ingenol Mebutate—Infestation—Methotrexate—stomach cancer	0.000595	0.00651	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Methotrexate—stomach cancer	0.000578	0.00633	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Epirubicin—stomach cancer	0.000557	0.00609	CcSEcCtD
Ingenol Mebutate—Infestation—Epirubicin—stomach cancer	0.000557	0.00609	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Epirubicin—stomach cancer	0.000541	0.00592	CcSEcCtD
Ingenol Mebutate—Infection—Docetaxel—stomach cancer	0.000523	0.00572	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Docetaxel—stomach cancer	0.000516	0.00565	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Doxorubicin—stomach cancer	0.000515	0.00564	CcSEcCtD
Ingenol Mebutate—Infestation—Doxorubicin—stomach cancer	0.000515	0.00564	CcSEcCtD
Ingenol Mebutate—Infection—Capecitabine—stomach cancer	0.000506	0.00554	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Doxorubicin—stomach cancer	0.000501	0.00548	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Capecitabine—stomach cancer	0.0005	0.00547	CcSEcCtD
Ingenol Mebutate—Eye disorder—Methotrexate—stomach cancer	0.000499	0.00546	CcSEcCtD
Ingenol Mebutate—Headache—Irinotecan—stomach cancer	0.000477	0.00522	CcSEcCtD
Ingenol Mebutate—Eye disorder—Epirubicin—stomach cancer	0.000467	0.00511	CcSEcCtD
Ingenol Mebutate—Erythema—Methotrexate—stomach cancer	0.000465	0.00509	CcSEcCtD
Ingenol Mebutate—Headache—Fluorouracil—stomach cancer	0.000457	0.005	CcSEcCtD
Ingenol Mebutate—Erythema—Epirubicin—stomach cancer	0.000435	0.00476	CcSEcCtD
Ingenol Mebutate—Eye disorder—Doxorubicin—stomach cancer	0.000432	0.00473	CcSEcCtD
Ingenol Mebutate—Erythema—Doxorubicin—stomach cancer	0.000402	0.00441	CcSEcCtD
Ingenol Mebutate—Infection—Methotrexate—stomach cancer	0.000377	0.00413	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Methotrexate—stomach cancer	0.000372	0.00407	CcSEcCtD
Ingenol Mebutate—Infection—Epirubicin—stomach cancer	0.000353	0.00386	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Epirubicin—stomach cancer	0.000348	0.00381	CcSEcCtD
Ingenol Mebutate—Headache—Docetaxel—stomach cancer	0.00033	0.00361	CcSEcCtD
Ingenol Mebutate—Infection—Doxorubicin—stomach cancer	0.000326	0.00357	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Doxorubicin—stomach cancer	0.000322	0.00353	CcSEcCtD
Ingenol Mebutate—Headache—Capecitabine—stomach cancer	0.000319	0.0035	CcSEcCtD
Ingenol Mebutate—Headache—Methotrexate—stomach cancer	0.000238	0.0026	CcSEcCtD
Ingenol Mebutate—Headache—Epirubicin—stomach cancer	0.000222	0.00243	CcSEcCtD
Ingenol Mebutate—Headache—Doxorubicin—stomach cancer	0.000206	0.00225	CcSEcCtD
Ingenol Mebutate—PRKCD—Gene Expression—SERPINE1—stomach cancer	6.36e-05	8.97e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—stomach cancer	6.34e-05	8.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PPP2R1A—stomach cancer	6.31e-05	8.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6R—stomach cancer	6.3e-05	8.89e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPP2R1A—stomach cancer	6.27e-05	8.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FYN—stomach cancer	6.26e-05	8.83e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN2A—stomach cancer	6.17e-05	8.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic M-M/G1 phases—MAPK1—stomach cancer	6.12e-05	8.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN1B—stomach cancer	6.11e-05	8.62e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—HRAS—stomach cancer	6.06e-05	8.55e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—PIK3CA—stomach cancer	5.94e-05	8.38e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CXCL8—stomach cancer	5.93e-05	8.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SERPINE1—stomach cancer	5.9e-05	8.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—PIK3CA—stomach cancer	5.9e-05	8.32e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGFR2—stomach cancer	5.88e-05	8.29e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CCND1—stomach cancer	5.83e-05	8.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SMAD4—stomach cancer	5.83e-05	8.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PPP2R1A—stomach cancer	5.82e-05	8.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CD44—stomach cancer	5.74e-05	8.1e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ERBB2—stomach cancer	5.71e-05	8.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HSPB1—stomach cancer	5.71e-05	8.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AGTR2—stomach cancer	5.71e-05	8.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—RHOA—stomach cancer	5.69e-05	8.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—F2R—stomach cancer	5.64e-05	7.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—BMP2—stomach cancer	5.64e-05	7.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN1A—stomach cancer	5.64e-05	7.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS3—stomach cancer	5.63e-05	7.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ERBB2—stomach cancer	5.63e-05	7.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—HRAS—stomach cancer	5.6e-05	7.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FYN—stomach cancer	5.56e-05	7.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKR1C3—stomach cancer	5.55e-05	7.83e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—HRAS—stomach cancer	5.49e-05	7.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HTR1A—stomach cancer	5.49e-05	7.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN1B—stomach cancer	5.46e-05	7.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—HRAS—stomach cancer	5.46e-05	7.7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SMAD4—stomach cancer	5.41e-05	7.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IRS2—stomach cancer	5.38e-05	7.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PRKCB—stomach cancer	5.32e-05	7.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—ERCC2—stomach cancer	5.32e-05	7.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ANXA1—stomach cancer	5.3e-05	7.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDKN1B—stomach cancer	5.29e-05	7.46e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ERBB2—stomach cancer	5.27e-05	7.44e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IL6—stomach cancer	5.26e-05	7.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IL6—stomach cancer	5.22e-05	7.37e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGFR2—stomach cancer	5.22e-05	7.37e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CAV1—stomach cancer	5.22e-05	7.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CCND1—stomach cancer	5.21e-05	7.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CDKN1B—stomach cancer	5.21e-05	7.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APOA1—stomach cancer	5.21e-05	7.35e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL1B—stomach cancer	5.19e-05	7.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—stomach cancer	5.15e-05	7.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADRB1—stomach cancer	5.14e-05	7.25e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FYN—stomach cancer	5.14e-05	7.25e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN1A—stomach cancer	5.04e-05	7.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—JUN—stomach cancer	5.03e-05	7.1e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PRKCB—stomach cancer	4.97e-05	7.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—JUN—stomach cancer	4.96e-05	7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6ST—stomach cancer	4.95e-05	6.98e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERCC2—stomach cancer	4.94e-05	6.97e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RPS6—stomach cancer	4.91e-05	6.93e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDKN1B—stomach cancer	4.88e-05	6.89e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDKN1A—stomach cancer	4.88e-05	6.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPP2R1A—stomach cancer	4.88e-05	6.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PRKCB—stomach cancer	4.83e-05	6.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGFR2—stomach cancer	4.82e-05	6.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—stomach cancer	4.82e-05	6.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CDKN1A—stomach cancer	4.81e-05	6.79e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6ST—stomach cancer	4.81e-05	6.79e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MAPK3—stomach cancer	4.81e-05	6.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSTP1—stomach cancer	4.78e-05	6.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IRS2—stomach cancer	4.78e-05	6.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MAPK8—stomach cancer	4.76e-05	6.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APC—stomach cancer	4.75e-05	6.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—HMOX1—stomach cancer	4.72e-05	6.66e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MAPK8—stomach cancer	4.7e-05	6.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MYC—stomach cancer	4.68e-05	6.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTHFR—stomach cancer	4.64e-05	6.55e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MAPK1—stomach cancer	4.58e-05	6.46e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—MAPK3—stomach cancer	4.56e-05	6.43e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—MAPK3—stomach cancer	4.55e-05	6.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HBEGF—stomach cancer	4.51e-05	6.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDKN1A—stomach cancer	4.5e-05	6.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TYMS—stomach cancer	4.45e-05	6.28e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IRS2—stomach cancer	4.41e-05	6.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6R—stomach cancer	4.41e-05	6.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PRKCB—stomach cancer	4.41e-05	6.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSTM1—stomach cancer	4.4e-05	6.2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6ST—stomach cancer	4.39e-05	6.2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—STAT3—stomach cancer	4.35e-05	6.14e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—MAPK1—stomach cancer	4.33e-05	6.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—MAPK1—stomach cancer	4.33e-05	6.11e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—stomach cancer	4.33e-05	6.11e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MAPK3—stomach cancer	4.3e-05	6.07e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6R—stomach cancer	4.29e-05	6.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CAV1—stomach cancer	4.28e-05	6.04e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOA1—stomach cancer	4.27e-05	6.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—RHOA—stomach cancer	4.27e-05	6.02e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MYC—stomach cancer	4.18e-05	5.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADRB2—stomach cancer	4.16e-05	5.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MAPK3—stomach cancer	4.16e-05	5.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—PIK3CA—stomach cancer	4.14e-05	5.84e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MAPK3—stomach cancer	4.14e-05	5.84e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ERCC2—stomach cancer	4.13e-05	5.83e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SERPINE1—stomach cancer	4.13e-05	5.83e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MAPK3—stomach cancer	4.1e-05	5.79e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—KRAS—stomach cancer	4.09e-05	5.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—KRAS—stomach cancer	4.09e-05	5.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MAPK1—stomach cancer	4.09e-05	5.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PPP2R1A—stomach cancer	4.08e-05	5.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6ST—stomach cancer	4.06e-05	5.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARG—stomach cancer	4.05e-05	5.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MYC—stomach cancer	4.02e-05	5.68e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—STAT3—stomach cancer	4.02e-05	5.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RHOA—stomach cancer	3.99e-05	5.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MAPK1—stomach cancer	3.96e-05	5.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—stomach cancer	3.96e-05	5.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOS3—stomach cancer	3.95e-05	5.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CASP8—stomach cancer	3.93e-05	5.55e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6R—stomach cancer	3.92e-05	5.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MAPK1—stomach cancer	3.9e-05	5.51e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—stomach cancer	3.9e-05	5.51e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APC—stomach cancer	3.9e-05	5.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDH1—stomach cancer	3.89e-05	5.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MTHFR—stomach cancer	3.89e-05	5.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—RHOA—stomach cancer	3.88e-05	5.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MAPK3—stomach cancer	3.84e-05	5.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SMAD4—stomach cancer	3.79e-05	5.34e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PIK3CA—stomach cancer	3.76e-05	5.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PIK3CA—stomach cancer	3.76e-05	5.3e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CXCL8—stomach cancer	3.75e-05	5.29e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KRAS—stomach cancer	3.74e-05	5.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MYC—stomach cancer	3.74e-05	5.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ERBB2—stomach cancer	3.69e-05	5.21e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—KRAS—stomach cancer	3.69e-05	5.2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MAPK1—stomach cancer	3.65e-05	5.16e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—stomach cancer	3.65e-05	5.15e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SERPINE1—stomach cancer	3.65e-05	5.15e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—stomach cancer	3.64e-05	5.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6R—stomach cancer	3.62e-05	5.11e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FYN—stomach cancer	3.6e-05	5.07e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CAV1—stomach cancer	3.58e-05	5.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOA1—stomach cancer	3.58e-05	5.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CXCL8—stomach cancer	3.5e-05	4.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HRAS—stomach cancer	3.48e-05	4.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—HRAS—stomach cancer	3.48e-05	4.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—KRAS—stomach cancer	3.45e-05	4.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PIK3CA—stomach cancer	3.43e-05	4.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—stomach cancer	3.43e-05	4.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDKN1B—stomach cancer	3.42e-05	4.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CXCL8—stomach cancer	3.4e-05	4.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SERPINE1—stomach cancer	3.39e-05	4.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PIK3CA—stomach cancer	3.39e-05	4.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGFR2—stomach cancer	3.38e-05	4.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL6—stomach cancer	3.33e-05	4.7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERBB2—stomach cancer	3.28e-05	4.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—RHOA—stomach cancer	3.27e-05	4.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCND1—stomach cancer	3.26e-05	4.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—JUN—stomach cancer	3.25e-05	4.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS3—stomach cancer	3.24e-05	4.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HRAS—stomach cancer	3.18e-05	4.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PIK3CA—stomach cancer	3.17e-05	4.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP9—stomach cancer	3.17e-05	4.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDKN1A—stomach cancer	3.15e-05	4.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARG—stomach cancer	3.15e-05	4.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HRAS—stomach cancer	3.13e-05	4.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IRS2—stomach cancer	3.09e-05	4.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MAPK8—stomach cancer	3.08e-05	4.34e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL6—stomach cancer	3.04e-05	4.29e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDKN1B—stomach cancer	3.04e-05	4.28e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERBB2—stomach cancer	3.03e-05	4.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IL6—stomach cancer	3e-05	4.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CAV1—stomach cancer	3e-05	4.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOA1—stomach cancer	2.99e-05	4.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL1B—stomach cancer	2.98e-05	4.21e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—stomach cancer	2.96e-05	4.18e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HRAS—stomach cancer	2.93e-05	4.14e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—JUN—stomach cancer	2.89e-05	4.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRKCB—stomach cancer	2.85e-05	4.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—stomach cancer	2.84e-05	4.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6ST—stomach cancer	2.84e-05	4.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ALB—stomach cancer	2.83e-05	4e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—STAT3—stomach cancer	2.81e-05	3.97e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6—stomach cancer	2.81e-05	3.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDKN1B—stomach cancer	2.8e-05	3.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDKN1A—stomach cancer	2.8e-05	3.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MAPK8—stomach cancer	2.74e-05	3.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APC—stomach cancer	2.73e-05	3.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NOS3—stomach cancer	2.71e-05	3.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MAPK3—stomach cancer	2.69e-05	3.79e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MYC—stomach cancer	2.62e-05	3.69e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—MAPK3—stomach cancer	2.61e-05	3.69e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDKN1A—stomach cancer	2.59e-05	3.65e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MAPK1—stomach cancer	2.56e-05	3.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—stomach cancer	2.56e-05	3.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6R—stomach cancer	2.54e-05	3.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—STAT3—stomach cancer	2.5e-05	3.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—MAPK1—stomach cancer	2.49e-05	3.51e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—stomach cancer	2.49e-05	3.51e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—stomach cancer	2.48e-05	3.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KRAS—stomach cancer	2.42e-05	3.41e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MAPK3—stomach cancer	2.39e-05	3.37e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CA—stomach cancer	2.38e-05	3.35e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MAPK3—stomach cancer	2.38e-05	3.35e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SERPINE1—stomach cancer	2.37e-05	3.35e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—KRAS—stomach cancer	2.35e-05	3.32e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MYC—stomach cancer	2.31e-05	3.26e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—STAT3—stomach cancer	2.31e-05	3.26e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RHOA—stomach cancer	2.29e-05	3.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MAPK1—stomach cancer	2.27e-05	3.21e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—stomach cancer	2.27e-05	3.21e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOS3—stomach cancer	2.27e-05	3.2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CA—stomach cancer	2.22e-05	3.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MAPK3—stomach cancer	2.21e-05	3.11e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CA—stomach cancer	2.16e-05	3.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—stomach cancer	2.15e-05	3.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KRAS—stomach cancer	2.15e-05	3.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MYC—stomach cancer	2.15e-05	3.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ERBB2—stomach cancer	2.12e-05	2.99e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MAPK1—stomach cancer	2.1e-05	2.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—stomach cancer	2.1e-05	2.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HRAS—stomach cancer	2.05e-05	2.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CXCL8—stomach cancer	2.01e-05	2.84e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—HRAS—stomach cancer	2e-05	2.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—KRAS—stomach cancer	1.98e-05	2.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PIK3CA—stomach cancer	1.97e-05	2.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6—stomach cancer	1.97e-05	2.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDKN1B—stomach cancer	1.96e-05	2.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6—stomach cancer	1.91e-05	2.7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCND1—stomach cancer	1.87e-05	2.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—JUN—stomach cancer	1.87e-05	2.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HRAS—stomach cancer	1.82e-05	2.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PIK3CA—stomach cancer	1.82e-05	2.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP9—stomach cancer	1.82e-05	2.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDKN1A—stomach cancer	1.81e-05	2.56e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MAPK8—stomach cancer	1.77e-05	2.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6—stomach cancer	1.75e-05	2.46e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HRAS—stomach cancer	1.68e-05	2.38e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—stomach cancer	1.63e-05	2.3e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STAT3—stomach cancer	1.62e-05	2.28e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6—stomach cancer	1.61e-05	2.28e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MAPK3—stomach cancer	1.54e-05	2.18e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CA—stomach cancer	1.53e-05	2.15e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MYC—stomach cancer	1.5e-05	2.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MAPK1—stomach cancer	1.47e-05	2.07e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—stomach cancer	1.47e-05	2.07e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KRAS—stomach cancer	1.39e-05	1.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CA—stomach cancer	1.28e-05	1.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—stomach cancer	1.23e-05	1.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HRAS—stomach cancer	1.18e-05	1.66e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6—stomach cancer	1.13e-05	1.59e-05	CbGpPWpGaD
